Set Your Location to See Relevant Information

Setting your location helps us to show you nearby providers and locations based on your healthcare needs.

Stamford Health is committed to stopping the spread of COVID-19. For details regarding the resumption of services and reopening of facilities, how to help and FAQs, visit here. 

A Prospective Observational Study to Estimate the Incidence of Febrile Neutropenia (FN) Among Subjects with Non-myeloid Malignancies at High Risk for FN and Receiving Neulasta® (pegfilgrastim) Onpro® kit or Other Physician Choice Options for Prophylaxis of FN (Amgen 20170758)

Study Details

This is a multicenter, prospective, observational cohort study in subjects receiving myelosuppressive chemotherapy for a non-myeloid malignancy and are considered at high risk for developing FN.

ClinicalTrials.gov NCT number
NCT not applicable

Principal Investigators

  • Steve Lo, MD
Sponsor(s)
Amgen
Contact
Ian Goff at 203-358-8879
or officeofresearch@stamhealth.org

Location

  • Bennett Cancer Center
    One Hospital Plaza
    Stamford, CT 06902
    Main: 203-276-2695

Our website uses cookies

This website uses cookies to give you the very best experience. Your continued use of this site is considered permission by you to use cookies in this manner. Please review our Privacy Policy and Terms of Use for more information about the data we collect and the types of cookies we use. Please note, if you link off our website to a 3rd party site of any kind, that website has its own terms and conditions.